Tuesday - April 1, 2025
Antithrombin Blood Test From Siemens Healthineers Now FDA Cleared as a Companion Diagnostic for Qfitlia, a Sanofi Hemophilia Therapy
March 29, 2025
MALVERN, Pennsylvania, March 29 -- Siemens Healthineers, a medical technology company, issued the following news release on March 28, 2025:

* * *

Antithrombin Blood Test from Siemens Healthineers Now FDA Cleared as a Companion Diagnostic for Qfitlia, a Sanofi Hemophilia Therapy

* The assay now can measure antithrombin (AT) activity levels for people treated with Qfitlia

* Measuring AT activity levels helps people receive the appropriate dose, . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products